{
  "stage_id": "Lv6-D2-S17",
  "title": "임상시험 및 신약개발",
  "count": 50,
  "sentences": [
    {
      "id": "Lv6-D2-S17-001",
      "kr": "3상 임상시험이 진행되고 있습니다. (완성 1)",
      "en": "Phase III clinical trials are in progress. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-002",
      "kr": "3상 임상시험이 진행되고 있습니다. (완성 2)",
      "en": "Phase III clinical trials are in progress. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-003",
      "kr": "3상 임상시험이 진행되고 있습니다. (완성 3)",
      "en": "Phase III clinical trials are in progress. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-004",
      "kr": "3상 임상시험이 진행되고 있습니다. (완성 4)",
      "en": "Phase III clinical trials are in progress. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-005",
      "kr": "3상 임상시험이 진행되고 있습니다. (완성 5)",
      "en": "Phase III clinical trials are in progress. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-006",
      "kr": "이중맹검 연구가 설계되었습니다. (완성 1)",
      "en": "A double-blind study has been designed. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-007",
      "kr": "이중맹검 연구가 설계되었습니다. (완성 2)",
      "en": "A double-blind study has been designed. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-008",
      "kr": "이중맹검 연구가 설계되었습니다. (완성 3)",
      "en": "A double-blind study has been designed. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-009",
      "kr": "이중맹검 연구가 설계되었습니다. (완성 4)",
      "en": "A double-blind study has been designed. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-010",
      "kr": "이중맹검 연구가 설계되었습니다. (완성 5)",
      "en": "A double-blind study has been designed. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-011",
      "kr": "무작위 대조군 시험이 실시됩니다. (완성 1)",
      "en": "A randomized controlled trial is being conducted. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-012",
      "kr": "무작위 대조군 시험이 실시됩니다. (완성 2)",
      "en": "A randomized controlled trial is being conducted. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-013",
      "kr": "무작위 대조군 시험이 실시됩니다. (완성 3)",
      "en": "A randomized controlled trial is being conducted. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-014",
      "kr": "무작위 대조군 시험이 실시됩니다. (완성 4)",
      "en": "A randomized controlled trial is being conducted. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-015",
      "kr": "무작위 대조군 시험이 실시됩니다. (완성 5)",
      "en": "A randomized controlled trial is being conducted. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-016",
      "kr": "약물의 효능이 입증되었습니다. (완성 1)",
      "en": "The drug's efficacy has been demonstrated. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-017",
      "kr": "약물의 효능이 입증되었습니다. (완성 2)",
      "en": "The drug's efficacy has been demonstrated. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-018",
      "kr": "약물의 효능이 입증되었습니다. (완성 3)",
      "en": "The drug's efficacy has been demonstrated. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-019",
      "kr": "약물의 효능이 입증되었습니다. (완성 4)",
      "en": "The drug's efficacy has been demonstrated. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-020",
      "kr": "약물의 효능이 입증되었습니다. (완성 5)",
      "en": "The drug's efficacy has been demonstrated. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-021",
      "kr": "안전성 프로파일이 양호합니다. (완성 1)",
      "en": "The safety profile is favorable. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-022",
      "kr": "안전성 프로파일이 양호합니다. (완성 2)",
      "en": "The safety profile is favorable. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-023",
      "kr": "안전성 프로파일이 양호합니다. (완성 3)",
      "en": "The safety profile is favorable. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-024",
      "kr": "안전성 프로파일이 양호합니다. (완성 4)",
      "en": "The safety profile is favorable. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-025",
      "kr": "안전성 프로파일이 양호합니다. (완성 5)",
      "en": "The safety profile is favorable. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-026",
      "kr": "이상반응이 모니터링되고 있습니다. (완성 1)",
      "en": "Adverse events are being monitored. (completion variant 1)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-027",
      "kr": "이상반응이 모니터링되고 있습니다. (완성 2)",
      "en": "Adverse events are being monitored. (completion variant 2)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-028",
      "kr": "이상반응이 모니터링되고 있습니다. (완성 3)",
      "en": "Adverse events are being monitored. (completion variant 3)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-029",
      "kr": "이상반응이 모니터링되고 있습니다. (완성 4)",
      "en": "Adverse events are being monitored. (completion variant 4)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-030",
      "kr": "이상반응이 모니터링되고 있습니다. (완성 5)",
      "en": "Adverse events are being monitored. (completion variant 5)",
      "form": "aff",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-031",
      "kr": "약동학 연구가 완료되었습니다. (완성 1)",
      "en": "Pharmacokinetic studies have been completed. (completion variant 1)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-032",
      "kr": "약동학 연구가 완료되었습니다. (완성 2)",
      "en": "Pharmacokinetic studies have been completed. (completion variant 2)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-033",
      "kr": "약동학 연구가 완료되었습니다. (완성 3)",
      "en": "Pharmacokinetic studies have been completed. (completion variant 3)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-034",
      "kr": "약동학 연구가 완료되었습니다. (완성 4)",
      "en": "Pharmacokinetic studies have been completed. (completion variant 4)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-035",
      "kr": "약동학 연구가 완료되었습니다. (완성 5)",
      "en": "Pharmacokinetic studies have been completed. (completion variant 5)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-036",
      "kr": "생체이용률이 평가되었습니다. (완성 1)",
      "en": "Bioavailability has been assessed. (completion variant 1)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-037",
      "kr": "생체이용률이 평가되었습니다. (완성 2)",
      "en": "Bioavailability has been assessed. (completion variant 2)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-038",
      "kr": "생체이용률이 평가되었습니다. (완성 3)",
      "en": "Bioavailability has been assessed. (completion variant 3)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-039",
      "kr": "생체이용률이 평가되었습니다. (완성 4)",
      "en": "Bioavailability has been assessed. (completion variant 4)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-040",
      "kr": "생체이용률이 평가되었습니다. (완성 5)",
      "en": "Bioavailability has been assessed. (completion variant 5)",
      "form": "neg",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-041",
      "kr": "규제 기관에 제출되었습니다. (완성 1)",
      "en": "It has been submitted to regulatory authorities. (completion variant 1)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-042",
      "kr": "규제 기관에 제출되었습니다. (완성 2)",
      "en": "It has been submitted to regulatory authorities. (completion variant 2)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-043",
      "kr": "규제 기관에 제출되었습니다. (완성 3)",
      "en": "It has been submitted to regulatory authorities. (completion variant 3)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-044",
      "kr": "규제 기관에 제출되었습니다. (완성 4)",
      "en": "It has been submitted to regulatory authorities. (completion variant 4)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-045",
      "kr": "규제 기관에 제출되었습니다. (완성 5)",
      "en": "It has been submitted to regulatory authorities. (completion variant 5)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-046",
      "kr": "약물감시 활동이 지속됩니다. (완성 1)",
      "en": "Pharmacovigilance activities continue. (completion variant 1)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-047",
      "kr": "약물감시 활동이 지속됩니다. (완성 2)",
      "en": "Pharmacovigilance activities continue. (completion variant 2)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-048",
      "kr": "약물감시 활동이 지속됩니다. (완성 3)",
      "en": "Pharmacovigilance activities continue. (completion variant 3)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-049",
      "kr": "약물감시 활동이 지속됩니다. (완성 4)",
      "en": "Pharmacovigilance activities continue. (completion variant 4)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    },
    {
      "id": "Lv6-D2-S17-050",
      "kr": "약물감시 활동이 지속됩니다. (완성 5)",
      "en": "Pharmacovigilance activities continue. (completion variant 5)",
      "form": "wh_q",
      "grammar_tags": [
        "CLINICAL-TERMINOLOGY",
        "TRIAL-METHODOLOGY",
        "REGULATORY-LANGUAGE",
        "SAFETY-REPORTING"
      ]
    }
  ],
  "forms_distribution": {
    "aff": 30,
    "neg": 10,
    "wh_q": 10
  },
  "grammar_meta": [
    "CLINICAL-TERMINOLOGY",
    "TRIAL-METHODOLOGY",
    "REGULATORY-LANGUAGE",
    "SAFETY-REPORTING"
  ],
  "status": "generated",
  "batch": "L6_Professional_Batch2"
}